2020 St. Jude / PIDS Pediatric Transplant ID Symposium March 12, 2020 banner

 

Dear All –

 

St Jude and PIDS leadership have made the difficult decision to cancel the upcoming St. Jude/PIDS Conference due to the increasing spread of COVID-19.   This decision was made after several days of deliberation with the conference organizers, PIDS leadership, and the St. Jude Infection Prevention Team.  Out of an abundance of caution, we want to avoid unnecessary exposures to the immunocompromised children of St. Jude; moreover, there is simply no effective way to rapidly screen for the virus and attendees will be travelling from international and national sites, which further confuses risk calculation. 

 

We know that this decision will affect you all in a number of ways, but we trust that you understand that this is an evolving issue that requires utmost caution. For those who submitted abstracts for presentation, please know that we still plan to publish these in their entirety in an upcoming issue of JPIDS. If you have any other questions or concerns, please feel free to reach out to our PIDS staff at pids@idsociety.org.

 

PIDS will continue to update our membership on COVID-19 developments. We wish you all the best as you care for your local communities and advance research on this and other microbes that threaten pediatric health.

 

Onward and upward,

Elaine and Buddy

 

 

 

 

The 2020 St. Jude Children's Research Hospital and PIDS' Pediatric Immunocompromised Hosts and Transplant ID Symposium: Bench to Bedside will be held on Thursday, March 12, 2020 at the St. Jude Children’s Research Hospital in Memphis, Tennessee.

The meeting will feature leaders in the field presenting cutting edge information relevant to the immunocompromised host including CAR-T cell therapies, hemophagocytic lymphohistiocytosis, viral specific T cell therapy, updates on viral infections and immunizations in solid organ transplant recipients, and antimicrobial resistance in immunocompromised hosts. Interactive breakout sessions will highlight challenging cases and focus on current diagnosis, treatment and management of infectious complications in pediatric patients with immunocompromising conditions or those undergoing transplantation. Research updates will be featured throughout the day, through presentations and poster sessions. Participants will have the opportunity to interact with experts on the day of the symposium through a panel Q&A and the evening preceding the symposium through roundtable sessions to informally discuss research opportunities, careers in transplant infectious diseases, and the role of pharmacists and advanced practice providers in the care of immunocompromised patients.

Target Audience:

Fellows and faculty in pediatric infectious diseases and transplantation medicine as well as other healthcare providers with an interest in transplant ID and immunocompromised hosts.

Objectives:

  • Update on current diagnosis, treatment and management of infectious complications pediatric immunocompromised patients.
  • Understand advances in viral infections, T cell therapies and management of HLH.
  • Appreciate prevention of viral disease through T cell transfer and vaccination.
  • Consider research gaps in transplant ID.
  • Understand the impact of antimicrobial resistance in immunocompromised hosts.

Registration/Housing

Program

Biographies

Abstract Submissions

Call for Cases

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of St. Jude Children’s Research Hospital and the Pediatric Infectious Diseases Society. St. Jude Children’s Research Hospital is accredited by the ACCME to provide continuing medical education for physicians.